<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e651d-9b5f-7a55-9fed-78ac47ca9eec,g:b425a278-5b4d-4dc1-a188-5526d4c63dcf-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:vrdn="http://www.viridiantherapeutics.com/20260630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.viridiantherapeutics.com/20260630">
  <xs:import namespace="http://fasb.org/srt/2026" schemaLocation="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2026" schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2026" schemaLocation="https://xbrl.sec.gov/dei/2026/dei-2026.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2026" schemaLocation="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vrdn-20260630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vrdn-20260630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vrdn-20260630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vrdn-20260630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.viridiantherapeutics.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.viridiantherapeutics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>9952151 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.viridiantherapeutics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>9952152 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" roleURI="http://www.viridiantherapeutics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS">
        <link:definition>9952153 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSParenthetical" roleURI="http://www.viridiantherapeutics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSParenthetical">
        <link:definition>9952154 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.viridiantherapeutics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>9952155 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" roleURI="http://www.viridiantherapeutics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical">
        <link:definition>9952156 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.viridiantherapeutics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>9952157 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFTHEBUSINESS" roleURI="http://www.viridiantherapeutics.com/role/DESCRIPTIONOFTHEBUSINESS">
        <link:definition>9952158 - Disclosure - DESCRIPTION OF THE BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.viridiantherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>9952159 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTS" roleURI="http://www.viridiantherapeutics.com/role/MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTS">
        <link:definition>9952160 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTANGIBLEASSETNET" roleURI="http://www.viridiantherapeutics.com/role/INTANGIBLEASSETNET">
        <link:definition>9952161 - Disclosure - INTANGIBLE ASSET, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDLIABILITIES" roleURI="http://www.viridiantherapeutics.com/role/ACCRUEDLIABILITIES">
        <link:definition>9952162 - Disclosure - ACCRUED LIABILITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://www.viridiantherapeutics.com/role/DEBT">
        <link:definition>9952163 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PURCHASEANDSALEOFTHEREVENUEPARTICIPATIONRIGHT" roleURI="http://www.viridiantherapeutics.com/role/PURCHASEANDSALEOFTHEREVENUEPARTICIPATIONRIGHT">
        <link:definition>9952164 - Disclosure - PURCHASE AND SALE OF THE REVENUE PARTICIPATION RIGHT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COLLABORATIONANDLICENSEAGREEMENTS" roleURI="http://www.viridiantherapeutics.com/role/COLLABORATIONANDLICENSEAGREEMENTS">
        <link:definition>9952165 - Disclosure - COLLABORATION AND LICENSE AGREEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.viridiantherapeutics.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>9952166 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CAPITALSTOCK" roleURI="http://www.viridiantherapeutics.com/role/CAPITALSTOCK">
        <link:definition>9952167 - Disclosure - CAPITAL STOCK</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATION" roleURI="http://www.viridiantherapeutics.com/role/SHAREBASEDCOMPENSATION">
        <link:definition>9952168 - Disclosure - SHARE-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETLOSSPERSHARE" roleURI="http://www.viridiantherapeutics.com/role/NETLOSSPERSHARE">
        <link:definition>9952169 - Disclosure - NET LOSS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATION" roleURI="http://www.viridiantherapeutics.com/role/SEGMENTINFORMATION">
        <link:definition>9952170 - Disclosure - SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.viridiantherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>9955511 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSTables" roleURI="http://www.viridiantherapeutics.com/role/MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSTables">
        <link:definition>9955512 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTANGIBLEASSETNETTables" roleURI="http://www.viridiantherapeutics.com/role/INTANGIBLEASSETNETTables">
        <link:definition>9955513 - Disclosure - INTANGIBLE ASSET, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDLIABILITIESTables" roleURI="http://www.viridiantherapeutics.com/role/ACCRUEDLIABILITIESTables">
        <link:definition>9955514 - Disclosure - ACCRUED LIABILITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTTables" roleURI="http://www.viridiantherapeutics.com/role/DEBTTables">
        <link:definition>9955515 - Disclosure - DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PURCHASEANDSALEOFTHEREVENUEPARTICIPATIONRIGHTTables" roleURI="http://www.viridiantherapeutics.com/role/PURCHASEANDSALEOFTHEREVENUEPARTICIPATIONRIGHTTables">
        <link:definition>9955516 - Disclosure - PURCHASE AND SALE OF THE REVENUE PARTICIPATION RIGHT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONTables" roleURI="http://www.viridiantherapeutics.com/role/SHAREBASEDCOMPENSATIONTables">
        <link:definition>9955517 - Disclosure - SHARE-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETLOSSPERSHARETables" roleURI="http://www.viridiantherapeutics.com/role/NETLOSSPERSHARETables">
        <link:definition>9955518 - Disclosure - NET LOSS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONTables" roleURI="http://www.viridiantherapeutics.com/role/SEGMENTINFORMATIONTables">
        <link:definition>9955519 - Disclosure - SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFTHEBUSINESSDetails" roleURI="http://www.viridiantherapeutics.com/role/DESCRIPTIONOFTHEBUSINESSDetails">
        <link:definition>9955520 - Disclosure - DESCRIPTION OF THE BUSINESS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" roleURI="http://www.viridiantherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails">
        <link:definition>9955521 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSScheduleofDebtSecuritiesAvailableforsaleDetails" roleURI="http://www.viridiantherapeutics.com/role/MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSScheduleofDebtSecuritiesAvailableforsaleDetails">
        <link:definition>9955522 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS - Schedule of Debt Securities, Available-for-sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSNarrativeDetails" roleURI="http://www.viridiantherapeutics.com/role/MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSNarrativeDetails">
        <link:definition>9955523 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" roleURI="http://www.viridiantherapeutics.com/role/MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails">
        <link:definition>9955524 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTANGIBLEASSETNETNarrativeDetails" roleURI="http://www.viridiantherapeutics.com/role/INTANGIBLEASSETNETNarrativeDetails">
        <link:definition>9955525 - Disclosure - INTANGIBLE ASSET, NET - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTANGIBLEASSETNETScheduleofEstimatedFutureAmortizationExpenseDetails" roleURI="http://www.viridiantherapeutics.com/role/INTANGIBLEASSETNETScheduleofEstimatedFutureAmortizationExpenseDetails">
        <link:definition>9955526 - Disclosure - INTANGIBLE ASSET, NET - Schedule of Estimated Future Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDLIABILITIESDetails" roleURI="http://www.viridiantherapeutics.com/role/ACCRUEDLIABILITIESDetails">
        <link:definition>9955527 - Disclosure - ACCRUED LIABILITIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTNarrativeDetails" roleURI="http://www.viridiantherapeutics.com/role/DEBTNarrativeDetails">
        <link:definition>9955528 - Disclosure - DEBT - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTScheduleofLongTermDebtInstrumentsDetails" roleURI="http://www.viridiantherapeutics.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails">
        <link:definition>9955529 - Disclosure - DEBT - Schedule of Long-Term Debt Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PURCHASEANDSALEOFTHEREVENUEPARTICIPATIONRIGHTNarrativeDetails" roleURI="http://www.viridiantherapeutics.com/role/PURCHASEANDSALEOFTHEREVENUEPARTICIPATIONRIGHTNarrativeDetails">
        <link:definition>9955530 - Disclosure - PURCHASE AND SALE OF THE REVENUE PARTICIPATION RIGHT - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PURCHASEANDSALEOFTHEREVENUEPARTICIPATIONRIGHTActivityofLiabilityDetails" roleURI="http://www.viridiantherapeutics.com/role/PURCHASEANDSALEOFTHEREVENUEPARTICIPATIONRIGHTActivityofLiabilityDetails">
        <link:definition>9955531 - Disclosure - PURCHASE AND SALE OF THE REVENUE PARTICIPATION RIGHT - Activity of Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PURCHASEANDSALEOFTHEREVENUEPARTICIPATIONRIGHTActivityOfDerivativeLiabilityDetails" roleURI="http://www.viridiantherapeutics.com/role/PURCHASEANDSALEOFTHEREVENUEPARTICIPATIONRIGHTActivityOfDerivativeLiabilityDetails">
        <link:definition>9955532 - Disclosure - PURCHASE AND SALE OF THE REVENUE PARTICIPATION RIGHT - Activity Of Derivative Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COLLABORATIONANDLICENSEAGREEMENTSDetails" roleURI="http://www.viridiantherapeutics.com/role/COLLABORATIONANDLICENSEAGREEMENTSDetails">
        <link:definition>9955533 - Disclosure - COLLABORATION AND LICENSE AGREEMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://www.viridiantherapeutics.com/role/COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>9955534 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CAPITALSTOCKDetails" roleURI="http://www.viridiantherapeutics.com/role/CAPITALSTOCKDetails">
        <link:definition>9955535 - Disclosure - CAPITAL STOCK (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONBalancebyPlanDetails" roleURI="http://www.viridiantherapeutics.com/role/SHAREBASEDCOMPENSATIONBalancebyPlanDetails">
        <link:definition>9955536 - Disclosure - SHARE-BASED COMPENSATION - Balance by Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONNarrativeDetails" roleURI="http://www.viridiantherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails">
        <link:definition>9955537 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails" roleURI="http://www.viridiantherapeutics.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails">
        <link:definition>9955538 - Disclosure - SHARE-BASED COMPENSATION - Summary of RSU Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONStockOptionActivityDetails" roleURI="http://www.viridiantherapeutics.com/role/SHAREBASEDCOMPENSATIONStockOptionActivityDetails">
        <link:definition>9955539 - Disclosure - SHARE-BASED COMPENSATION - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONFairValueAssumptionforStockOptionsDetails" roleURI="http://www.viridiantherapeutics.com/role/SHAREBASEDCOMPENSATIONFairValueAssumptionforStockOptionsDetails">
        <link:definition>9955540 - Disclosure - SHARE-BASED COMPENSATION - Fair Value Assumption for Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONAllocationofSharebasedCompensationExpenseonStatementsofOperationsDetails" roleURI="http://www.viridiantherapeutics.com/role/SHAREBASEDCOMPENSATIONAllocationofSharebasedCompensationExpenseonStatementsofOperationsDetails">
        <link:definition>9955541 - Disclosure - SHARE-BASED COMPENSATION - Allocation of Share-based Compensation Expense on Statements of Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONAllocationofSharebasedCompensationExpenseonStatementsofOperationsDetails_1" roleURI="http://www.viridiantherapeutics.com/role/SHAREBASEDCOMPENSATIONAllocationofSharebasedCompensationExpenseonStatementsofOperationsDetails_1">
        <link:definition>9955541 - Disclosure - SHARE-BASED COMPENSATION - Allocation of Share-based Compensation Expense on Statements of Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETLOSSPERSHAREScheduleofEarningsPerShareBasicandDilutedDetails" roleURI="http://www.viridiantherapeutics.com/role/NETLOSSPERSHAREScheduleofEarningsPerShareBasicandDilutedDetails">
        <link:definition>9955542 - Disclosure - NET LOSS PER SHARE - Schedule of Earnings Per Share, Basic and Diluted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETLOSSPERSHAREScheduleofPotentialDilutiveSecuritiesDetails" roleURI="http://www.viridiantherapeutics.com/role/NETLOSSPERSHAREScheduleofPotentialDilutiveSecuritiesDetails">
        <link:definition>9955543 - Disclosure - NET LOSS PER SHARE - Schedule of Potential Dilutive Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONNarrativeDetails" roleURI="http://www.viridiantherapeutics.com/role/SEGMENTINFORMATIONNarrativeDetails">
        <link:definition>9955544 - Disclosure - SEGMENT INFORMATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONScheduleofSegmentReportingInformationbySegmentDetails" roleURI="http://www.viridiantherapeutics.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationbySegmentDetails">
        <link:definition>9955545 - Disclosure - SEGMENT INFORMATION - Schedule of Segment Reporting Information, by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONScheduleofSegmentReportingInformationbySegmentDetails_1" roleURI="http://www.viridiantherapeutics.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationbySegmentDetails_1">
        <link:definition>9955545 - Disclosure - SEGMENT INFORMATION - Schedule of Segment Reporting Information, by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="vrdn_CollaborationMember" abstract="true" name="CollaborationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_StockIssuedDuringPeriodValueWarrantsExercisedShares" abstract="false" name="StockIssuedDuringPeriodValueWarrantsExercisedShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="vrdn_StockIssuedDuringPeriodValueWarrantsExercisedValue" abstract="false" name="StockIssuedDuringPeriodValueWarrantsExercisedValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_NonCashLeaseExpense" abstract="false" name="NonCashLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_PurchaseAndSaleOfRevenueParticipationRightTextBlock" abstract="false" name="PurchaseAndSaleOfRevenueParticipationRightTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="vrdn_GoingConcernPolicyPolicyTextBlock" abstract="false" name="GoingConcernPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="vrdn_ImmunoGenIncMember" abstract="true" name="ImmunoGenIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_CollaborativeArrangementRightsAndObligationsMilestonePayment" abstract="false" name="CollaborativeArrangementRightsAndObligationsMilestonePayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_IntangibleAssetFiniteLivedEstimatedAmortizationExpenseAfterYearFour" abstract="false" name="IntangibleAssetFiniteLivedEstimatedAmortizationExpenseAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_AccruedOutsourcedManufacturingCurrent" abstract="false" name="AccruedOutsourcedManufacturingCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_AccruedMilestonePaymentCurrent" abstract="false" name="AccruedMilestonePaymentCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_AccruedOutsourcedClinicalAndNonclinicalStudiesCurrent" abstract="false" name="AccruedOutsourcedClinicalAndNonclinicalStudiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_ConvertibleSeniorNotesDue2032Member" abstract="true" name="ConvertibleSeniorNotesDue2032Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_HerculesTermLoanMember" abstract="true" name="HerculesTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_DebtInstrumentConvertibleTermsOfConversionAxis" abstract="true" name="DebtInstrumentConvertibleTermsOfConversionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="vrdn_DebtInstrumentConvertibleTermsOfConversionDomain" abstract="true" name="DebtInstrumentConvertibleTermsOfConversionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_DebtConversionTermsOneMember" abstract="true" name="DebtConversionTermsOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_DebtConversionTermsTwoMember" abstract="true" name="DebtConversionTermsTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_DebtCovenantPeriodAxis" abstract="true" name="DebtCovenantPeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="vrdn_DebtCovenantPeriodDomain" abstract="true" name="DebtCovenantPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_DebtCovenantPeriodOneMember" abstract="true" name="DebtCovenantPeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_DebtCovenantPeriodTwoMember" abstract="true" name="DebtCovenantPeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_DebtInstrumentAccordionFeatureIncreaseLimit" abstract="false" name="DebtInstrumentAccordionFeatureIncreaseLimit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_DebtInstrumentConvertibleRedemptionThresholdMinimumPrincipalAmountOutstanding" abstract="false" name="DebtInstrumentConvertibleRedemptionThresholdMinimumPrincipalAmountOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_DebtInstrumentNumberOfTranches" abstract="false" name="DebtInstrumentNumberOfTranches" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vrdn_DebtInstrumentFaceAmountFirstTranche" abstract="false" name="DebtInstrumentFaceAmountFirstTranche" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_DebtInstrumentFaceAmountSecondTranche" abstract="false" name="DebtInstrumentFaceAmountSecondTranche" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_DebtInstrumentFaceAmountThirdTranche" abstract="false" name="DebtInstrumentFaceAmountThirdTranche" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_DebtInstrumentFaceAmountFourthTranche" abstract="false" name="DebtInstrumentFaceAmountFourthTranche" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_DebtInstrumentFaceAmountFifthTranche" abstract="false" name="DebtInstrumentFaceAmountFifthTranche" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_SaleOfFutureRevenueMember" abstract="true" name="SaleOfFutureRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_SaleOfFutureRevenueMilestoneAndMarketingApprovalMember" abstract="true" name="SaleOfFutureRevenueMilestoneAndMarketingApprovalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_SaleOfFutureRevenueMilestoneMember" abstract="true" name="SaleOfFutureRevenueMilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_SaleOfFutureRevenueMarketingApprovalMember" abstract="true" name="SaleOfFutureRevenueMarketingApprovalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_SaleOfFutureRevenueNetSalesAchievementMember" abstract="true" name="SaleOfFutureRevenueNetSalesAchievementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_SaleOfFutureRevenueAgreedUponFinancialTermsMember" abstract="true" name="SaleOfFutureRevenueAgreedUponFinancialTermsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_SaleOfFutureRevenueRoyaltyPaymentsTier1Member" abstract="true" name="SaleOfFutureRevenueRoyaltyPaymentsTier1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_SaleOfFutureRevenueRoyaltyPaymentsTier2Member" abstract="true" name="SaleOfFutureRevenueRoyaltyPaymentsTier2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_SaleOfFutureRevenueRoyaltyPaymentsTier3Member" abstract="true" name="SaleOfFutureRevenueRoyaltyPaymentsTier3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_SaleOfFutureRevenueRoyaltyPaymentsTier4Member" abstract="true" name="SaleOfFutureRevenueRoyaltyPaymentsTier4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_VeligrotugMember" abstract="true" name="VeligrotugMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_ElegrobartMember" abstract="true" name="ElegrobartMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_DebtInstrumentConditionalPayments" abstract="false" name="DebtInstrumentConditionalPayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_DebtInstrumentConditionalPaymentsSalesAchievementThreshold" abstract="false" name="DebtInstrumentConditionalPaymentsSalesAchievementThreshold" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_DebtInstrumentRoyaltyPaymentsPercentage" abstract="false" name="DebtInstrumentRoyaltyPaymentsPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vrdn_DebtInstrumentRoyaltyPaymentsThreshold" abstract="false" name="DebtInstrumentRoyaltyPaymentsThreshold" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_MilestoneAchieved" abstract="false" name="MilestoneAchieved" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_DerivativeLiabilityRollForward" abstract="true" name="DerivativeLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vrdn_ZenasBioPharmaMember" abstract="true" name="ZenasBioPharmaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_ParagonTherapeuticsMember" abstract="true" name="ParagonTherapeuticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_KisseiPharmaceuticalCo.LtdMember" abstract="true" name="KisseiPharmaceuticalCo.LtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_FairmountFundsManagementMember" abstract="true" name="FairmountFundsManagementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_EnableInjectionsMember" abstract="true" name="EnableInjectionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_CollaborationArrangementFutureDevelopmentsMilestonePaymentObligation" abstract="false" name="CollaborationArrangementFutureDevelopmentsMilestonePaymentObligation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_CollaborationArrangementMaximumMilestonePayments" abstract="false" name="CollaborationArrangementMaximumMilestonePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_CollaborationArrangementMilestonePaymentIntellectualPropertyRightsDevelopmentMaximum" abstract="false" name="CollaborationArrangementMilestonePaymentIntellectualPropertyRightsDevelopmentMaximum" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_CollaborationArrangementCommercialMilestonePaymentIntellectualPropertyRightsDevelopmentMaximum" abstract="false" name="CollaborationArrangementCommercialMilestonePaymentIntellectualPropertyRightsDevelopmentMaximum" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_ResearchAndDevelopmentExpenseUnpaid" abstract="false" name="ResearchAndDevelopmentExpenseUnpaid" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_CollaborativeArrangementUpfrontFeePayment" abstract="false" name="CollaborativeArrangementUpfrontFeePayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_CollaborativeArrangementNumberOfPerformanceObligations" abstract="false" name="CollaborativeArrangementNumberOfPerformanceObligations" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vrdn_CollaborativeArrangementPotentialRoyaltyPaymentsMaximum" abstract="false" name="CollaborativeArrangementPotentialRoyaltyPaymentsMaximum" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_CollaborationArrangementPotentialMilestonePaymentMaximum" abstract="false" name="CollaborationArrangementPotentialMilestonePaymentMaximum" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_CollaborativeArrangementRightsAndObligationsMilestonesAchieved" abstract="false" name="CollaborativeArrangementRightsAndObligationsMilestonesAchieved" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_CollaborativeArrangementRightsAndLicensesFee" abstract="false" name="CollaborativeArrangementRightsAndLicensesFee" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_WuXiBiologicsHongKongLimitedWuXiMember" abstract="true" name="WuXiBiologicsHongKongLimitedWuXiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_VeligrotugDrugSubstanceMember" abstract="true" name="VeligrotugDrugSubstanceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_VeligrotugDrugProductMember" abstract="true" name="VeligrotugDrugProductMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_LongTermPurchaseCommitmentRenewalPeriod" abstract="false" name="LongTermPurchaseCommitmentRenewalPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="vrdn_LongTermPurchaseCommitmentNonRenewalNoticePeriodPriorToExpirationOfCurrentTerm" abstract="false" name="LongTermPurchaseCommitmentNonRenewalNoticePeriodPriorToExpirationOfCurrentTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="vrdn_LongTermPurchaseCommitmentPeriodVolumeRequirement" abstract="false" name="LongTermPurchaseCommitmentPeriodVolumeRequirement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="vrdn_A2026PublicOfferingMember" abstract="true" name="A2026PublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_March2025ATMAgreementMember" abstract="true" name="March2025ATMAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_SaleofStockCommissionFeePercentageofGrossSaleProceeds" abstract="false" name="SaleofStockCommissionFeePercentageofGrossSaleProceeds" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vrdn_InducementGrantsMember" abstract="true" name="InducementGrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_A2020PlanMember" abstract="true" name="A2020PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_A2016EmployeeStockPurchasePlanMember" abstract="true" name="A2016EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_A2025EmployeeStockPurchasePlanMember" abstract="true" name="A2025EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_NetIncomeLossAttributableToParentAllocation" abstract="false" name="NetIncomeLossAttributableToParentAllocation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_CommonStockWarrantsMember" abstract="true" name="CommonStockWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_ReportableSegmentMember" abstract="true" name="ReportableSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_ResearchAndDevelopmentExpenseExcludingShareBasedCompensationExpense" abstract="false" name="ResearchAndDevelopmentExpenseExcludingShareBasedCompensationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_SellingGeneralAndAdministrativeExpenseExcludingShareBasedCompensationExpense" abstract="false" name="SellingGeneralAndAdministrativeExpenseExcludingShareBasedCompensationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
